Clinical Trial Update: Naltrexone & SSRI in Alcoholics With Depression/PTSD [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of naltrexone and an SSRI in individuals with alcohol use disorder and comorbid depression and PTSD; results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Major Depressive Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Naltrexone (Naltrexone)
• SSRI (unspecified)

Snippet

Sponsor: Yale University | Conditions: Alcoholism, Depression | Phase 3 | Status: COMPLETED | Results posted: 2016-02-05